Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | LIN28A | Q9H9Z2 | 1/20 | 0.68 |
| ▸ | TERT | O14746 | 1/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.46 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.46 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | KCNA5 | P22460 | 3/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29898520 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2MAPTLIN28ATERT | |
| SCHEMBL1051354 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2MAPTLIN28ATERT | |
| SCHEMBL29402044 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2MAPTLIN28ATERT | |
| SCHEMBL15177847 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2MAPTLIN28ATERT | |
| SCHEMBL230599 | 0.98 | TDP1 (0.70) | TDP1SMN1; SMN2MAPTLIN28ATERT | |
| SCHEMBL825181 | 0.97 | TDP1 (0.69) | TDP1SMN1; SMN2MAPTLIN28ATERT | |
| SCHEMBL1332466 | 0.97 | TDP1 (0.69) | TDP1SMN1; SMN2MAPTLIN28ATERT | |
| SCHEMBL825403 | 0.97 | TDP1 (0.69) | TDP1SMN1; SMN2MAPTLIN28ATERT | |
| SCHEMBL27681560 | 0.97 | TDP1 (0.62) | TDP1SMN1; SMN2MAPTLIN28ATERT | |
| SCHEMBL3936898 | 0.94 | TDP1 (0.59) | TDP1SMN1; SMN2MAPTLIN28ATERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431673-A | Preparation method of extremely cold special oil product viscosity index improver | 新乡市瑞丰新材料股份有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-116023577-B | Amphiphilic copper-containing polymer nanoparticle and preparation and application thereof | 浙江大学 | 2023-10-03 | — | — | CN | claimed |
| CN-114775264-B | Method for preparing nitrogen halamine type antibacterial cotton fabric by ATRP method | 安徽大学 | 2023-06-23 | — | — | CN | claimed |
| CN-116023577-A | Amphiphilic copper-containing polymer nanoparticle and preparation and application thereof | 浙江大学 | 2023-04-28 | — | — | CN | claimed |
| CN-114159629-B | High-speed preparation method of blood vessel covered stent for emergency treatment of sudden coronary perforation in operation | 哈尔滨工业大学 | 2023-03-24 | — | — | CN | claimed |
| CN-113195644-B | Coating against a substrate by in situ polymerization | 汉高股份有限及两合公司 | 2023-01-24 | — | — | CN | claimed |
| CN-114775264-A | Method for preparing N-halamine type antibacterial cotton fabric by ATRP (atom transfer radical polymerization) method | 安徽大学 | 2022-07-22 | — | — | CN | claimed |
| CN-114159629-A | High-speed preparation method of blood vessel covered stent for emergency treatment of sudden coronary perforation in operation | 哈尔滨工业大学 | 2022-03-11 | — | — | CN | claimed |
| US-20200163899-A1 | FUNCTIONALIZED PRUSSIAN BLUE NANOPARTICLES, COMBINATION PRUSSIAN BLUE NANOPARTICLE-BASED NANO-IMMUNOTHERAPY AND APPLICATIONS THEREOF | CHILDREN'S NATIONAL MEDICAL CENTER (US) | 2020-05-28 | — | — | US | claimed |
| EP-3426300-A1 | FUNCTIONALIZED PRUSSIAN BLUE NANOPARTICES, COMBINATION PRUSSIAN BLUE NANOPARTICLE-BASED NANO-IMMUNOTHERAPHY AND APPLICATIONS THEREOF | CHILDREN'S NATIONAL MEDICAL CENTER (US) | 2019-01-16 | — | — | EP | claimed |
| EP-3397276-A1 | ANTIBODIES AND CONJUGATES THEREOF | Kodiak Sciences Inc. (US) | 2018-11-07 | — | — | EP | claimed |
| CN-108712911-A | Antibody and its conjugate | 科达制药股份有限公司 | 2018-10-26 | — | — | CN | claimed |
| WO-2017156148-A1 | FUNCTIONALIZED PRUSSIAN BLUE NANOPARTICES, COMBINATION PRUSSIAN BLUE NANOPARTICLE-BASED NANO-IMMUNOTHERAPHY AND APPLICATIONS THEREOF | FERNANDES ROHAN (US) | 2017-09-14 | — | — | WO | claimed |
| WO-2017117464-A1 | ANTIBODIES AND CONJUGATES THEREOF | KODIAK SCIENCES INC. (US) | 2017-07-06 | — | — | WO | claimed |
| EP-4724108-A2 | COMPOSITIONS OF CONJUGATED AND UNCONJUGATED PROTEINS | Kodiak Sciences Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4649959-A2 | METHODS OF TREATING AN EYE DISORDER | Kodiak Sciences Inc. (US) | 2025-11-19 | — | — | EP | disclosed |
| US-12466879-B2 | Complement factor D antagonist antibodies and conjugates thereof | KODIAK SCIENCES INC. (US) | 2025-11-11 | — | — | US | disclosed |
| WO-2007025086-A2 | ATOM TRANSFER RADICAL POLYMERIZATION IN MICROEMULSION AND TRUE EMULSION POLYMERIZATION | CARNEGIE MELLON UNIVERSITY (US) | 2007-03-01 | — | — | WO | disclosed |
| EP-1725590-A1 | ATOM TRANSFER RADICAL POLYMERIZATION PROCESS | CARNEGIE-MELLON UNIVERSITY (US) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005087819-A1 | ATOM TRANSFER RADICAL POLYMERIZATION PROCESS | CARNEGIE MELLON UNIVERSITY (US) | 2005-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12466879-B2 | Complement factor D antagonist antibodies and conjugates thereof | CFD, CFH, CFB | TDP1 4046/4885SMN1; SMN2 3074/4885MAPT 1956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.